Skip to main content
Fig. 6 | Stem Cell Research & Therapy

Fig. 6

From: Optimized administration of human embryonic stem cell-derived immunity-and-matrix regulatory cells for mouse lung injury and fibrosis

Fig. 6

Knockout of CD24 reduces the efficacy of IMRCs in treating lung injury and fibrosis. a Schematic diagram of animal experiment plan. b Weight and mortality statistics of different groups of mice. c Representative histology of lung sections stained with H&E. Scale bar, 200 µm. d Evaluate the fibrosis changes in the lungs of mice using the Ashcroft scale. The Ashcroft score was measured in the H&E section of the lungs. The data was represented as mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001

Back to article page